Literature DB >> 25220089

Cognitive behavioral therapy for adolescents with ADHD.

Kevin M Antshel1, Amy K Olszewski2.   

Abstract

Attention deficit/hyperactivity disorder (ADHD) often persists into adolescence and has the same functional impairments as were present during childhood. Medications lessen ADHD symptoms yet do not reliably affect functioning. Thus, there exists a great need for psychosocial treatments in adolescents with ADHD. Nonetheless, relative to the vast literature that has been reported on children with ADHD, much less data have been reported about psychosocial interventions for adolescents with ADHD. Cognitive behavioral therapy interventions that are being used with adolescents rely more on traditional behavioral principles than cognitive therapy tenets.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADHD; Adolescence; Adolescent; CBT; Cognitive behavioral therapy

Mesh：

Year:  2014        PMID： 25220089     DOI： 10.1016/j.chc.2014.05.001

Source DB:  PubMed          Journal:  Child Adolesc Psychiatr Clin N Am        ISSN： 1056-4993


  10 in total

1.  Two novel CBTs for adolescents with ADHD: the value of planning skills.

Authors:  Bianca E Boyer; Hilde M Geurts; Pier J M Prins; Saskia Van der Oord
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-12-31       Impact factor: 4.785

2.  Academic Skills Groups for Middle School Children With ADHD in the Outpatient Mental Health Setting: An Open Trial.

Authors:  Heather A Ciesielski; Leanne Tamm; Aaron J Vaughn; Jessica E M Cyran; Jeffery N Epstein
Journal:  J Atten Disord       Date:  2015-04-29       Impact factor: 3.256

Review 3.  Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder During Adolescence in the Primary Care Setting: A Concise Review.

Authors:  Khyati Brahmbhatt; Donald M Hilty; Mina Hah; Jaesu Han; Kathy Angkustsiri; Julie B Schweitzer
Journal:  J Adolesc Health       Date:  2016-05-18       Impact factor: 5.012

4.  Pharmacological Management of Pediatric Patients with Comorbid Attention-Deficit Hyperactivity Disorder Oppositional Defiant Disorder.

Authors:  Daniel F Connor
Journal:  Paediatr Drugs       Date:  2015-10       Impact factor: 3.022

5.  Personality to Prescription Drug Misuse in Adolescents: Testing Affect Regulation, Psychological Dysregulation, and Deviance Proneness Pathways.

Authors:  Sherry H Stewart; Annie Chinneck; Kara Thompson; Mohammad H Afzali; Raquel Nogueira-Arjona; Ioan T Mahu; Patricia J Conrod
Journal:  Front Psychiatry       Date:  2021-04-27       Impact factor: 4.157

Review 6.  Recognizing Psychiatric Comorbidity With Reading Disorders.

Authors:  Robert L Hendren; Stephanie L Haft; Jessica M Black; Nancy Cushen White; Fumiko Hoeft
Journal:  Front Psychiatry       Date:  2018-03-27       Impact factor: 4.157

7.  Neurofunctional and behavioural measures associated with fMRI-neurofeedback learning in adolescents with Attention-Deficit/Hyperactivity Disorder.

Authors:  Sheut-Ling Lam; Marion Criaud; Analucia Alegria; Gareth J Barker; Vincent Giampietro; Katya Rubia
Journal:  Neuroimage Clin       Date:  2020-05-26       Impact factor: 4.881

8.  Evaluation of a structured skills training group for adolescents with attention deficit/hyperactivity disorder (ADHD) - study protocol of a randomised controlled trial.

Authors:  Jenny Meyer; Mia Ramklint; Maria Unenge Hallerbäck; Måns Lööf; Johan Isaksson
Journal:  BMC Psychiatry       Date:  2019-06-10       Impact factor: 3.630

9.  Differences in Real World Executive Function between Children with Pediatric Bipolar Disorder and Children with ADHD.

Authors:  Alessandra M Passarotti; Nidhi Trivedi; Liza Dominguez-Colman; Manharkumar Patel; Scott A Langenecker
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2016-11-01

10.  Qualitative Treatment-Subgroup Interactions in a Randomized Clinical Trial of Treatments for Adolescents with ADHD: Exploring What Cognitive-Behavioral Treatment Works for Whom.

Authors:  Bianca E Boyer; Lisa L Doove; Hilde M Geurts; Pier J M Prins; Iven Van Mechelen; Saskia Van der Oord
Journal:  PLoS One       Date:  2016-03-15       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.